Specifications

Product Data
Applications	IHC, PEP-ELISA, WB
Recommended Dilution	ELISA: 1:32,000. WB: 0.3-1ug/ml.IHC:5µg/ml
Reactivities	Human, Mouse (Expected from sequence similarity: Rat, Cow)
Host	Goat
Isotype	IgG
Clonality	Polyclonal
Immunogen	Peptide with sequence C-DSKTGALHSRLDL, from the C Terminus of the protein sequence according to NP_075555.
Formulation	Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Concentration	lot specific
Purification	Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. Aliquot and store at -20°C. Minimize freezing and thawing.
Conjugation	Unconjugated
Storage	Store at -20°C as received.
Stability	Stable for 12 months from date of receipt.
Gene Name	forkhead box L2
Database Link	NP_075555 Entrez Gene 26927 MouseEntrez Gene 367152 RatEntrez Gene 668 Human UniProt ID P58012
Background	Defects in FOXL2 are a cause of blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) [MIM:110100]; also known as blepharophimosis syndrome. It is an autosomal dominant disorder characterized by eyelid dysplasia, small palpebral fissures, drooping eyelids and a skin fold running inward and upward from the lower lid. In type I BPSE (BPES1) eyelid abnormalities are associated with female infertility. Affected females show an ovarian deficit due to primary amenorrhea or to premature ovarian failure (POF). In type II BPSE (BPES2) affected individuals show only the eyelid defects. There is a mutational hotspot in the region coding for the poly-Ala domain, since 30% of all mutations in the ORF lead to poly-Ala expansions, resulting mainly in BPES type II.
Synonyms	BPES; BPES1; PFRK; PINTO; POF3
Reference Data
Protein Families	Druggable Genome, Transcription Factors